Manoj K Valluru Selected Research

acifluorfen (Blazer)

7/2021

Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manoj K Valluru Research Topics

Disease

3	Disease Progression 07/2021 - 01/2020
3	Autosomal Dominant Polycystic Kidney (ADPKD) 07/2021 - 01/2020
3	Neoplasms (Cancer) 01/2021 - 08/2019
2	Inflammation (Inflammations) 07/2021 - 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Uveal melanoma 08/2019

Drug/Important Bio-Agent (IBA)

2	Messenger RNA (mRNA)IBA 01/2021 - 08/2019
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
1	acifluorfen (Blazer)IBA 07/2021
1	Pioglitazone (Actos)FDA Link 07/2021
1	Tolvaptan FDA Link 07/2021
1	Insulin (Novolin)FDA Link 07/2021
1	ThiazolidinedionesIBA 07/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 08/2019

Therapy/Procedure

1	Therapeutics 01/2021